Using immunohistochemistry, Harb et al. (2019) showed that the phenol-like eugenol attenuated NAFLD by down regulating hepatic TRPV1 (Harb et al., 2019). Here, TRPV1 is linked to metabolic dysfunction-associated steatotic liver disease.